FDA Approved: ZIRGAN — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved a supplemental application for ZIRGAN (ganciclovir ophthalmic gel) from Bausch & Lomb Incorporated, indicating a labeling update for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpetic Keratitis

Drugs mentioned

• ZIRGAN (GANCICLOVIR)

Snippet

SUPPL AP for ZIRGAN (GANCICLOVIR)